Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ballinger

Showing results (51-60 of 174) with videos related to

Pageof 18
Sort By:
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Technetium-99m spiperone dithiocarbamate: a potential radiopharmaceutical for dopamine receptor imaging with SPECTJ R Ballinger, K Y Gulenchyn, M N Hassan
Psychological Medicine|August 1, 1978
Behavioural syndromes identified by cluster analysis in a sample of 100 severely and profoundly retarded adultsA H Reid, B R Ballinger, B B Heather
International Journal of Cancer|May 18, 1999
Influence of cell concentration in limiting the therapeutic benefit of P-glycoprotein reversal agentsJ K Tunggal, J R Ballinger, I F Tannock
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1988
Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathioneJ R Ballinger, R H Reid, K Y Gulenchyn
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1985
Standardised Psychiatric Interview in elderly demented patientsG S Winslow, B R Ballinger, A M McHarg
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1975
Methods of assessment of drug administration in a psychiatric hospitalB R Ballinger, A C Ramsay, M J Stewart
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxiaJ R Ballinger, J W Kee, A M Rauth
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1989
Clinical use of technetium-99m HM-PAO for determination of brain deathR H Reid, K Y Gulenchyn, J R Ballinger
Epilepsia|July 1, 1992
Epileptic seizures in elderly patients with dementiaM J McAreavey, B R Ballinger, G W Fenton
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Stabilization of stannous pyrophosphate kits with gentisic acidJ R Ballinger, J Pygas, B Gerson, et al.
Pageof 18

Showing results (51-60 of 174) with videos related to

Sort By:
Pageof 18
International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes|January 1, 1989
Technetium-99m spiperone dithiocarbamate: a potential radiopharmaceutical for dopamine receptor imaging with SPECTJ R Ballinger, K Y Gulenchyn, M N Hassan
Psychological Medicine|August 1, 1978
Behavioural syndromes identified by cluster analysis in a sample of 100 severely and profoundly retarded adultsA H Reid, B R Ballinger, B B Heather
International Journal of Cancer|May 18, 1999
Influence of cell concentration in limiting the therapeutic benefit of P-glycoprotein reversal agentsJ K Tunggal, J R Ballinger, I F Tannock
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 1, 1988
Technetium-99m HM-PAO stereoisomers: differences in interaction with glutathioneJ R Ballinger, R H Reid, K Y Gulenchyn
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1985
Standardised Psychiatric Interview in elderly demented patientsG S Winslow, B R Ballinger, A M McHarg
The British Journal of Psychiatry : the Journal of Mental Science|November 1, 1975
Methods of assessment of drug administration in a psychiatric hospitalB R Ballinger, A C Ramsay, M J Stewart
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 1, 1996
In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxiaJ R Ballinger, J W Kee, A M Rauth
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1989
Clinical use of technetium-99m HM-PAO for determination of brain deathR H Reid, K Y Gulenchyn, J R Ballinger
Epilepsia|July 1, 1992
Epileptic seizures in elderly patients with dementiaM J McAreavey, B R Ballinger, G W Fenton
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Stabilization of stannous pyrophosphate kits with gentisic acidJ R Ballinger, J Pygas, B Gerson, et al.
Pageof 18